Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Dual-energy X-ray Absorptiometry
54%
Melanoma
45%
Tumor-infiltrating Lymphocytes
38%
Bone Metastasis
38%
Lower Limb Lymphedema
37%
Metastatic Colorectal Cancer (mCRC)
32%
Patients with Prostate Cancer
32%
Cetuximab
32%
Whole-body MRI
32%
Irinotecan
32%
Metabolic Response
29%
Metastatic Melanoma
28%
Melanoma Patients
27%
Adoptive Cell Therapy
27%
Bone Scan
26%
Response Evaluation
24%
Diagnostic Test Accuracy
23%
Lymphedema
23%
Planar Bone Scintigraphy
21%
Total Body Potassium
21%
SPECT-CT
21%
Weight Loss
21%
Tissue Composition
21%
Fat Mass
18%
Lower Limb
18%
Progressive Disease
16%
Metabolic Disease
16%
Body Composition
15%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
87%
Fluorine-18
54%
Melanoma
54%
Prostate Cancer
43%
Tumor Infiltrating Lymphocyte
35%
Bone Metastasis
35%
Bone Scintigraphy
32%
Limb
32%
Lymphedema
32%
Whole Body MRI
32%
Cell Therapy
24%
Dual-Energy X-Ray Absorptiometry
24%
Sodium Fluoride
23%
Treatment Response
23%
Cetuximab
21%
Metastatic Colorectal Cancer
21%
Single Photon Emission Computed Tomography-Computed Tomography
21%
Irinotecan
21%
Metabolism
20%
Metastatic Melanoma
17%
Progressive Disease
16%
Metastatic Carcinoma
16%
